Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 113
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Oregon Psilocybin Services Tracker: Q1 2025
Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics
Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning
Dylan Beynon – Mindbloom – At Home Ketamine
Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study
Psychedelic Bulletin #127: Psilocybin Shows Promise in Bipolar Disorder; Gilgamesh Raises...
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health...
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort...
First Patient Dosed in Small Pharma’s Drug Interaction Study
Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement
Revive Therapeutics Ltd. Expands Life Offering to Quebec
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT
Israeli Based Biotech Company Clearmind Medicine Inc’s CEO, Dr. Adi Zuloff-Shani,...
Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics,...
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE...
1
...
112
113
114
...
292
Page 113 of 292